The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non-Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study.

In terms of the intracranial ORR, the anlotinib plus WBRT group presented a greater intracranial ORR than the WBRT group did, although the difference did not reach statistical significance (71.4% vs. 53.5%, p = 0.170).

also in 111,027 other papers

However, in our study, although patients with Lung‐molGPA 2.0–3.0 achieved numerically longer iPFS and OS compared to those with Lung‐molGPA 0–1.5, the difference failed to reach statistical significance.

also in 6,035 other papers